Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Thomas A. Hope, Emily K. Bergsland, Murat Fani Bozkurt, et al.
Journal of Nuclear Medicine (2017) Vol. 59, Iss. 1, pp. 66-74
Open Access | Times Cited: 285

Showing 1-25 of 285 citing articles:

Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives, Jonathan Strosberg
CA A Cancer Journal for Clinicians (2018) Vol. 68, Iss. 6, pp. 471-487
Open Access | Times Cited: 498
Liver metastases
Diamantis I. Tsilimigras, Pnina Brodt, Pierre‐Alain Clavien, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Closed Access | Times Cited: 350
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors
Jonathan Strosberg, Þorvarður R. Hálfdánarson, Andrew M. Bellizzi, et al.
Pancreas (2017) Vol. 46, Iss. 6, pp. 707-714
Open Access | Times Cited: 322
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors
James R. Howe, Nipun B. Merchant, Claudius Conrad, et al.
Pancreas (2019) Vol. 49, Iss. 1, pp. 1-33
Open Access | Times Cited: 309
Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT
Yasemin Şanlı, Ishan Garg, Asha Kandathil, et al.
American Journal of Roentgenology (2018) Vol. 211, Iss. 2, pp. 267-277
Closed Access | Times Cited: 171
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
Þorvarður R. Hálfdánarson, Jonathan Strosberg, Laura Tang, et al.
Pancreas (2020) Vol. 49, Iss. 7, pp. 863-881
Closed Access | Times Cited: 142
A critical assessment of technical advances in pharmaceutical removal from wastewater – A critical review
Vinay Kumar, Sivarama Krishna Lakkaboyana, Neha Sharma, et al.
Case Studies in Chemical and Environmental Engineering (2023) Vol. 8, pp. 100363-100363
Open Access | Times Cited: 70
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors
Thomas A. Hope, Martin Allen-Auerbach, Lisa Bodei, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 2, pp. 204-210
Open Access | Times Cited: 62
Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology
José Flávio Gomes Marin, Rafael Fernandes Nunes, Artur Martins Coutinho, et al.
Radiographics (2020) Vol. 40, Iss. 6, pp. 1715-1740
Closed Access | Times Cited: 137
NANETS/SNMMI Procedure Standard for Somatostatin Receptor–Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
Thomas A. Hope, Amanda Abbott, Karen Colucci, et al.
Journal of Nuclear Medicine (2019) Vol. 60, Iss. 7, pp. 937-943
Open Access | Times Cited: 130
Somatostatin receptor PET ligands - the next generation for clinical practice.
Elin Pauwels, Frederik Cleeren, Guy Bormans, et al.
PubMed (2018) Vol. 8, Iss. 5, pp. 311-331
Closed Access | Times Cited: 118
Role of biomarker tests for diagnosis of neuroendocrine tumours
Johannes Hofland, Wouter T. Zandee, Wouter W. de Herder
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 11, pp. 656-669
Closed Access | Times Cited: 105
The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management
Varune Rohan Ramnarine, Maxim Kobelev, Ewan A. Gibb, et al.
European Urology (2019) Vol. 76, Iss. 5, pp. 546-559
Open Access | Times Cited: 94
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines
Simron Singh, Emily K. Bergsland, Cynthia Card, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 10, pp. 1577-1598
Closed Access | Times Cited: 88
Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies
Lingaku Lee, Tetsuhide Ito, Robert T. Jensen
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 9, pp. 837-860
Open Access | Times Cited: 85
111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden
Thomas A. Hope, Jérémie Calais, Li Zhang, et al.
Journal of Nuclear Medicine (2019) Vol. 60, Iss. 9, pp. 1266-1269
Open Access | Times Cited: 80
[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2020) Vol. 47, Iss. 13, pp. 3033-3046
Closed Access | Times Cited: 75
Molecular imaging nanoprobes for theranostic applications
Haozhe He, Xindan Zhang, Lihua Du, et al.
Advanced Drug Delivery Reviews (2022) Vol. 186, pp. 114320-114320
Closed Access | Times Cited: 68
Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE
Claudia Ortega, Rebecca Wong, Josh Schaefferkoetter, et al.
Journal of Nuclear Medicine (2021) Vol. 62, Iss. 10, pp. 1406-1414
Open Access | Times Cited: 57
18F-AlF-NOTA-Octreotide Outperforms68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 4, pp. 632-638
Open Access | Times Cited: 45
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome
Antoine Tabarin, Guillaume Assié, Pascal Barat, et al.
Annales d Endocrinologie (2022) Vol. 83, Iss. 2, pp. 119-141
Open Access | Times Cited: 41
Prediction of177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Magdalena Mileva, Gwennaëlle Marin, Hugo Levillain, et al.
Journal of Nuclear Medicine (2023) Vol. 65, Iss. 2, pp. 236-244
Open Access | Times Cited: 24
Gastric neuroendocrine neoplasms
Giuseppe Lamberti, Francesco Panzuto, Marianne Pavel, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 13
The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?
Rudolf A. Werner, Alexander Weich, Malte Kircher, et al.
Theranostics (2018) Vol. 8, Iss. 22, pp. 6088-6100
Open Access | Times Cited: 70
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework
Rudolf A. Werner, Lilja B. Sólnes, Mehrbod S. Javadi, et al.
Journal of Nuclear Medicine (2018) Vol. 59, Iss. 7, pp. 1085-1091
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top